FOCUS NOBLE, LEADER DE LA FORMATION ET E L’INTÉGRATION DES PATIENTS AFondée par Jeff et Hayley Baker en 1994 et rejointe par Craig Baker en 1997, la société Noble est devenue le chef de file de la formation et de l’intégration des patients. Aider les patients à améliorer l’observance – et, au final, les résultats sanitaires – est la mission de Noble qui développe des dispositifs de formation et des plates-formes d’intégration pour les principaux fabricants d’auto-injecteurs, de seringues pré-remplies, d’appareils implantables et d’appareils respiratoires. Ces dispositifs d’entraînement imitent la sensation exacte, les forces et la fonction du véritable dispositif d’administration de médicaments, permettant aux patients de pratiquer tout au long de leur traitement. Société d’Aptar Pharma, Noble fait partie d’AptarGroup. NEMERA, A LEADER IN PATIENT TRAINING AND PATIENT ONBOARDING Founded by Jeff and Hayley Baker in 1994 and joined by Craig Baker in 1997, Noble has since grown as the leader in patient training and onboarding. With an unwavering com- mitment to helping patients improve adherence – and ultima- tely health outcomes – Noble’s team develops training devices and onboarding platforms for the industry’s leading manufac- turers of autoinjectors, prefilled syringes, implantable and res- piratory devices. These training devices mimic the exact feel, forces and function of the true drug delivery device, allowing patients to practice throughout their course of treatment. An Patient-focused Aptar Pharma company, Noble is part of AptarGroup. drug delivery devices Drug Delivery Devices Innovative developments Customized solutions GMP customer IP manufacturing the market.” Recent studies showed 86% of patients who use a self-injection therapy report increased confidence after practising with a training device that replicates the exact forces, feel and function of the true drug delivery device they use. Through this www.nemera.net partnership, Nemera works in full transpa- information@nemera.net • Phone: +33 (0)4 74 94 06 54 rency with Noble, to whom it has granted the rights to design, manufacture and distri- bute training andonboarding for its range of security systems. “Our ultimate goal is to provide our customers a safe, effective and differentiated combination product” , Séverine Duband concludes. September - 2020 / The Pharmaceutical Post 03 75 SECIVED